Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

SKYE
Skye Bioscience, Inc. Common Stock
stock NASDAQ

At Close
Aug 14, 2026 3:59:30 PM EDT
0.5015USD-7.301%(-0.0395)1,262,934
0.5900Bid   0.8100Ask   0.2200Spread
Pre-market
Aug 14, 2026 8:04:30 AM EDT
0.5410USD0.000%(0.0000)200
After-hours
Aug 12, 2026 4:50:30 PM EDT
0.5501USD+1.965%(+0.0106)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 10, 2022
07:00AM EST  Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a pharmaceutical company developing proprietary, synthetic, cannabinoid-derived molecules to treat diseases with significant unmet need, issued today the following letter from Chief Executive Officer and Chair, Punit Dhillon.   GlobeNewswire Inc
Jan 4, 2022
08:30AM EST  Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a biopharmaceutical company developing proprietary, synthetic, cannabinoid-derived molecules to treat diseases with significant unmet need, announced today that it will present a corporate overview at the H.C. Wainwright BIOCONNECT Conference, held virtually January 10-13, 2022.   GlobeNewswire Inc
Dec 23, 2021
07:27AM EST  Cannabis Movers & Shakers: Skye Bioscience, The Flowr Corp, Charlotte's Web, Rapid Dose Therapeutics   Benzinga
Dec 15, 2021
08:30AM EST  Skye Bioscience Announces Promotion of Tu Diep, MSc to Chief Development Officer   GlobeNewswire Inc
Oct 21, 2021
08:30AM EDT  Skye Bioscience Sponsored Research Presented at American   GlobeNewswire Inc
Oct 12, 2021
01:35PM EDT  Skye Bioscience Establishes New Cannabinoid Pharmaceutical   GlobeNewswire Inc
Oct 7, 2021
09:01AM EDT  Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has strengthened its management team with the appointment of Rhea Williams, MPH, as Head of Regulatory Affairs & Quality Assurance and Varun Khurana, PhD, as Senior Director of Research & Development.   GlobeNewswire Inc
Oct 5, 2021
08:30AM EDT  Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer   GlobeNewswire Inc
Sep 29, 2021
04:30PM EDT  Skye Bioscience Announces Closing of $7.0 Million Registered   GlobeNewswire Inc
Sep 27, 2021
09:30AM EDT  Skye Bioscience Announces $7.0 Million Registered Direct Offering   GlobeNewswire Inc
Sep 21, 2021
09:00AM EDT  Skye Bioscience Announces THCVHS Late-Breaking Preclinical   GlobeNewswire Inc
Sep 14, 2021
09:00AM EDT  Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, announced today that it will host a special virtual investor presentation on Tuesday, October 12. The filmed broadcast of this virtual event will be available beginning at 1 p.m. ET/10:00 a.m. PT.   GlobeNewswire Inc
Sep 7, 2021
08:30AM EDT  Skye Bioscience, Inc. (OTCQB: SKYE) (Skye), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, announced today that it will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually from September 13-15, 2021.   GlobeNewswire Inc
Aug 11, 2021
08:30AM EDT  Skye Bioscience to Present at the H.C. Wainwright Ophthalmology   GlobeNewswire Inc
Aug 10, 2021
08:30AM EDT  THCVHS shows no signs of chromosomal or gene mutations in preclinical studies   GlobeNewswire Inc
Aug 2, 2021
08:35AM EDT  Live Investor Conference & Webinar: OTCQB Venture Conference on August 5th   PR Newswire
Jul 26, 2021
08:30AM EDT  Skye Bioscience Appoints Biotech Executive Praveen Tyle, Ph.D. to   GlobeNewswire Inc
Jul 20, 2021
09:16AM EDT  These OTC Securities Had the Most Trading Activity in June   Benzinga
Jul 9, 2021
10:31AM EDT  Watch CV Sciences & Lyphe Group On The Benzinga Cannabis Hour   Benzinga
Jul 1, 2021
09:10AM EDT  Cannabis Industry Investor Presentations Now Available for On-Demand Viewing   PR Newswire
Jun 23, 2021
08:43AM EDT  Medolife Rx : FDA Accepts COVID-19 Clinical Study And Advises On Next Steps For Pre-IND Filing   RTTNews
Jun 10, 2021
08:30AM EDT  Skye Bioscience, Inc. (OTCQB: SKYE) (SKYE or the Company), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has expanded its Clinical Advisory Board with the appointment of ophthalmology expert and innovator, Miguel Gonzlez-Andrades, MD, PhD.   GlobeNewswire Inc
Jun 7, 2021
07:00AM EDT  EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 9th Emerging Growth Conference.   GlobeNewswire Inc
May 17, 2021
08:43AM EDT  Skye Biosciences THCVHS Demonstrates Superior   GlobeNewswire Inc
Apr 22, 2021
08:30AM EDT  -- Novel glaucoma drug ready for next development phase - GLP toxicology study on critical path to first human clinical trial -- Ongoing development of THCVHS includes near-term preclinical comparison with and in combinationwith leading glaucoma treatments and an assessment of neuroprotective properties   GlobeNewswire Inc
Apr 15, 2021
08:45AM EDT  Skye Bioscience to Present at Upcoming Investment Conferences in April   GlobeNewswire Inc
Apr 8, 2021
01:09PM EDT  Skye Bioscience Targets Unmet Needs Of Glaucoma Through Cannabinoids   Benzinga
Mar 26, 2021
04:39PM EDT  Highlights From Day 2 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 18, 2021
08:45AM EDT  Skye Bioscience to Present at Benzinga Biotech Small Cap Conference   GlobeNewswire Inc
Mar 16, 2021
08:30AM EDT  Skye Biosciences Cannabinoid-Derived Drug   GlobeNewswire Inc
Mar 8, 2021
08:47AM EST  Skye Bioscience Appoints Cannabinoid Science Experts Giovanni   GlobeNewswire Inc
Mar 3, 2021
08:38AM EST  Skye Bioscience to Present at H.C. Wainwright Global Life Sciences   GlobeNewswire Inc
Feb 23, 2021
09:02AM EST  Skye Bioscience Is Pursuing A New Kind Of Glaucoma Drug   Benzinga
Feb 8, 2021
08:35AM EST  Small and Microcap Company Investor Presentations Now Available for On-Demand   PR Newswire
Feb 3, 2021
09:10AM EST  Skye Bioscience to Participate in Investment Conferences in February   GlobeNewswire Inc
Jan 28, 2021
08:35AM EST  Live Investor Conference & Webinar: Small and Microcap Company Showcase on   PR Newswire
Jan 19, 2021
08:30AM EST  Emerald Bioscience Launches Rebrand Including Name Change to Skye   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC